| Nonpreferred Adalimumab - PA, NF - Standard Default |
Drug Name: Abrilada (adalimumab-afzb), Cyltezo (adalimumab-adbm), Hadlima (adalimumab-bwwd), Hulio (adalimumab-fkjp), Hyrimoz (adalimumab-adaz), Idacio (adalimumab-aacf), Simlandi (adalimumab-ryvk), Yuflyma (adalimumab-aaty), Yusimry (adalimumab-aqvh), Amjevita (adalimumab-atto), Humira (adalimumab) |
| NonStimulant ADHD Agents Step Therapy - ST, NF |
Intuniv (guanfacine extended-release), Kapvay (clonidine hydrochloride extended-release), Onyda XR (clonidine hydrochloride extended - release oral suspension), Qelbree (viloxazine extended-release), Strattera (atomoxetine) |
| Northera (droxidopa) |
Northera (droxidopa) |
| Nourianz (istradefylline) |
Nourianz (istradefylline) |
| Nplate (romiplostim) |
Nplate (romiplostim) |
| Nubeqa (darolutamide) |
Nubeqa (darolutamide) |
| Nucala (mepolizumab) |
Nucala (mepolizumab) |
| Nuedexta (dextromethorphan HBr/quinidine) |
Nuedexta (dextromethorphan HBr/quinidine) |
| Nulibry (fosdenopterin) |
Nulibry (fosdenopterin) |
| Nuplazid (pimavanserin) |
Nuplazid (pimavanserin) |
| Obesity GLP-1 Agonists – PA, NF |
Saxenda (liraglutide), Wegovy (semaglutide), Zepbound (tirzepatide) Injection |
| Ocaliva (obeticholic acid) |
Ocaliva (obeticholic acid) |
| Octreotide Products - PA, NF |
Mycapssa (octreotide capsule, delayed release), Sandostatin (octreotide acetate), Sandostatin LAR Depot (octreotide acetate) |
| Odomzo (sonidegib) |
Odomzo (sonidegib) |
| Ogsiveo (nirogacestat) |
Ogsiveo (nirogacestat) |
| Ohtuvayre (ensifentrine) - PA, NF |
Ohtuvayre (ensifentrine) |
| Ojemda (tovorafenib) |
Ojemda (tovorafenib) |
| Ojjaara (momelotinib) - PA, NF |
Ojjaara (momelotinib) |
| Olumiant (baricitinib) |
Olumiant (baricitinib) |
| Omega-3-Acid Derivatives |
Generic icosapent ethyl, Lovaza (omega-3-acid ethyl esters), Vascepa (icosapent ethyl) |